Pancreatic Cancer Research

ResearcherYamaguchi UniversityNo recent work listed

Kazuyuki Nakamura

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9128-5229; OpenAlex author ID A5000876079. Sources: OpenAlex.

Their work

Papers
16 (first author 0, last author 14)
Trials
0
Grants
0
Labs led
1
Collaborators
14
Papers, trials and grants by year

2011: 2 papers · 2012: 2 papers · 2013: 2 papers · 2014: 3 papers · 2015: 6 papers · 2016: none · 2017: 1 paper

Papers 16

  1. PI3K inhibitor LY294002, as opposed to wortmannin, enhances AKT phosphorylation in gemcitabine-resistant pancreatic cancer cells. Last author DOI 10.3892/ijo.2016.3804↗
  2. The Histone Deacetylase Inhibitor Valproic Acid Sensitizes Gemcitabine-Induced Cytotoxicity in Gemcitabine-Resistant Pancreatic Cancer Cells Possibly Through I… Last author DOI 10.1007/s11523-015-0370-0↗
  3. Cofilin-phosphatase slingshot-1L (SSH1L) is over-expressed in pancreatic cancer (PC) and contributes to tumor cell migration. Last author DOI 10.1016/j.canlet.2015.02.015↗
  4. Isolation of a growth factor stress-induced pancreatic cancer sub-population: insight into changes due to micro-environment. Co-author PMID 25770187↗
  5. Comparative proteomic analysis of two stress-management strategies in pancreatic cancer. Co-author PMID 25770192↗
  6. Resistance to gemcitabine in the pancreatic cancer cell line KLM1-R reversed by metformin action. Last author PMID 25862846↗
  7. High-mobility Group Box 1 and Mitogen-activated Protein Kinase activated Protein Kinase-2 Are Up-regulated in Gemcitabine-resistant Pancreatic Cancer Cells. Last author PMID 26124331↗
  8. Gemcitabine induces poly (ADP-ribose) polymerase-1 (PARP-1) degradation through autophagy in pancreatic cancer. Last author DOI 10.1371/journal.pone.0109076↗
  9. Active hexose-correlated compound down-regulates HSP27 of pancreatic cancer cells, and helps the cytotoxic effect of gemcitabine. Last author PMID 24403454↗
  10. Active hexose-correlated compound down-regulates sex-determining region Y-box 2 of pancreatic cancer cells. Last author PMID 25202061↗
  11. Up-regulation of DDX39 in human pancreatic cancer cells with acquired gemcitabine resistance compared to gemcitabine-sensitive parental cells. Last author PMID 23898070↗
  12. Human pancreatic cancer cells with acquired gemcitabine resistance exhibit significant up-regulation of peroxiredoxin-2 compared to sensitive parental cells. Last author PMID 24222118↗
  13. Proteomic differential display identifies upregulated vinculin as a possible biomarker of pancreatic cancer. Last author DOI 10.3892/or.2012.2004↗
  14. Heat-shock protein 27 plays the key role in gemcitabine-resistance of pancreatic cancer cells. Last author PMID 22641665↗
  15. KNK437 downregulates heat shock protein 27 of pancreatic cancer cells and enhances the cytotoxic effect of gemcitabine. Last author DOI 10.1159/000321019↗
  16. Proteomic differential display analysis for TS-1-resistant and -sensitive pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectromet… Last author PMID 21737628↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yasuhiro Kuramitsu · 16 shared papers, 2011–2017 · strength 0.73
  2. Yufeng Wang · 11 shared papers, 2012–2017 · strength 0.50
  3. Byron Baron · 9 shared papers, 2013–2017 · strength 0.48
  4. Yoshihiko Maehara · 10 shared papers, 2011–2017 · strength 0.46
  5. Isao Sakaida · 6 shared papers, 2011–2014 · strength 0.20
  6. Shigeyuki Suenaga · 5 shared papers, 2012–2014 · strength 0.18
  7. Kumiko Taba · 3 shared papers, 2011–2012 · strength 0.08
  8. Shomei Ryozawa · 3 shared papers, 2011–2012 · strength 0.08
  9. Masaaki Oka · 2 shared papers, 2012–2015 · strength 0.08
  10. Masayuki Tokunaga · 1 shared paper, 2015 · strength 0.06
  11. Junya Nawata · 1 shared paper, 2014 · strength 0.04
  12. Tomio Ueno · 1 shared paper, 2012 · strength 0.03
  13. Nobuaki Suzuki · 1 shared paper, 2012 · strength 0.03
  14. Kanako Yoshida · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.